Latest News for: metastatic tumor

Edit

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ̶ Strong Outlook for 2025

Pharmiweb 28 Mar 2025
... avelumab versus avelumab alone in patients with recurrent or metastatic HPV16-positive cervical and anogenital tumors did not meet its primary objective (improvement in progression-free survival).
Edit

Hyundai ADM Demonstrates Anti-Metastatic Effect of 'PenetriumTM' in TNBC Preclinical Study

Longview News-Journal 27 Mar 2025
– Simultaneous treatment of primary and metastatic tumors by eliminating pseudo-resistance ....
Edit

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance ...

ACCESSWIRE 26 Mar 2025
Xenetic is currently focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and locally advanced or metastatic solid tumors ... solid tumors.
Edit

TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering

Knoxville Daily Sun 26 Mar 2025
... metastatic disease ... The Company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis.
Edit

Angle PLC Announces Issue of LTIP Options and Share Options

ACCESSWIRE 21 Mar 2025
Allocation of LTIP options ... Total. 0%. 0 ... The Parsortix� PC1 system is an in vitro diagnostic device intended to enrich circulating tumor cells (CTCs) from peripheral blood collected in K2EDTA tubes from patients diagnosed with metastatic breast cancer.
Edit

Angle PLC Announces Results of Eisai Phase 2 pilot study

ACCESSWIRE 21 Mar 2025
Results of Eisai Phase 2 pilot study ... The Parsortix® PC1 system is an in vitro diagnostic device intended to enrich circulating tumor cells (CTCs) from peripheral blood collected in K2EDTA tubes from patients diagnosed with metastatic breast cancer.
Edit

Metastatic Liver Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ...

GetNews 19 Mar 2025
... in Solid Tumors (RECIST) version 1.1 ... In February 2025.- Tango Therapeutics Inc..- This is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion.
Edit

Metastatic Breast Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 19 Mar 2025
It covers the Metastatic Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products ... PMD-026 is a targeted oral agent designed to kill tumor cells in metastatic breast cancer ... Metastatic Breast Cancer Companies.
Edit

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results

ACCESSWIRE 19 Mar 2025
... of many human cancers, and our focus on advancing our systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and locally advanced or metastatic solid tumors.
Edit

Oncorena receives FDA approval to initiate studies in the US

Pharmiweb 18 Mar 2025
A Phase 1/2, open label, single arm study on safety, tolerability and anti-tumor efficacy of orellanine treatment in patients with metastatic clear-cell or papillary renal cell carcinoma (NCT05287945, ONC001-CL-001).
Edit

AdventHealth Tampa is first in Tampa Bay to offer implantable chemotherapy pump for patients with ...

Longview News-Journal 18 Mar 2025
Hepatic Artery Infusion therapy delivers treatment directly to metastatic tumors in the liver, while minimizing the potential for systemic side effects ....
Edit

Fecal transplants cured football coach’s stage 3 bowel cancer when chemo couldn’t

New York Post 18 Mar 2025
Michael Overman, came across a woman with metastatic colorectal cancer who had experienced a much better response to the drugs — her tumors had shrunk by 90% and, with a bit of surgery, she was cured.
Edit

Doctors dismissed my symptoms as a gluten allergy... but it was actually stage four colon ...

The Daily Mail 14 Mar 2025
... professionals - who told her she was too young for it to be something serious - before she found out that she had stage four metastatic colorectal cancer and tumors on her colon, ovary, and liver.
Edit

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) ...

ACCESSWIRE 14 Mar 2025
Calidi's novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors.
×